Skip to main content

Navigation group

Volumes

1,576 Publications

Clinical Trial

Published on 30 Jan 2020

VESTIGE: Adjuvant Immunotherapy in Patients With Resected Esophageal, Gastroesophageal Junction and Gastric Cancer Following Preoperative Chemotherapy With High Risk for Recurrence (N+ and/or R1): An Open Label Randomized Controlled Phase-2-Study

  • Elizabeth Smyth
  • Maren Knödler
  • Anne Giraut
  • Murielle Mauer
  • Magnus Nilsson
  • Nicole Van Grieken
  • Anna Dorothea Wagner
  • Markus Moehler
  • Florian Lordick
VESTIGE: Adjuvant Immunotherapy in Patients With Resected Esophageal, Gastroesophageal Junction and Gastric Cancer Following Preoperative Chemotherapy With High Risk for Recurrence (N+ and/or R1): An Open Label Randomized Controlled Phase-2-Study
Frontiers in Oncology
doi 10.3389/fonc.2019.01320
  • 10,777 views
  • 58 citations